Key result
Caldesmon inhibited actin-tropomyosin activation of myosin S1 MgATPase activity in a highly cooperative manner, requiring no more than one caldesmon bound per 10 actins for 90% inhibition.
Caldesmon regulates smooth muscle thin filament activity cooperatively via a tropomyosin-dependent mechanism similar to striated muscle troponin I.
Extends cooperative thin-filament regulation to smooth muscle; leaves open caldesmon as a therapeutic target in vascular disease.
We compared the mechanisms by which caldesmon inhibits actin and actin-tropomyosin activation of myosin subfragment 1 (S1) MgATPase activity. Caldesmon always inhibited actin activation by displacing S1.ADP.Pi from actin and inhibition required at least 0.7 caldesmon molecules bond per actin for 90% inhibition. Caldesmon inhibited actin-tropomyosin without any displacement of S1.ADP.Pi; thus it inhibits a rate-limiting step. Inhibition is highly cooperative, requiring no more than one caldesmon bound per 10 actins for 90% inhibition of activation by actin and smooth muscle tropomyosin. The degree of cooperativity is defined by the tropomyosin since inhibition by skeletal tropomyosin requires up to one caldesmon bound per 4 actins for 90% inhibition under identical conditions. Both noncooperative inhibition of actin and cooperative, tropomyosin-dependent, inhibition are manifested by a fragment of caldesmon containing only the C-terminal 99 amino acids (658C), although this fragment does not itself bind to tropomyosin. The functional properties of 658C are very similar to striated muscle troponin I, consequently we propose a similar mechanism for tropomyosin-dependent regulation by caldesmon. Caldesmon binding switches actin-tropomyosin to the "off" or "weak" state and Ca2+/calmodulin binding to caldesmon blocks this switch and thus reactivates the actin filament.
No takes yet. Share an insight, caveat, or question.
Marston et al. (1993) studied this question. Caldesmon was evaluated on Inhibition of actin and actin-tropomyosin activation of myosin subfragment 1 (S1) MgATPase activity. Caldesmon inhibited actin-tropomyosin activation of myosin S1 MgATPase activity in a highly cooperative manner, requiring no more than one caldesmon bound per 10 actins for 90% inhibition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: